UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Ametek
AME
|
$778M |
| 2 |
Microsoft
MSFT
|
$432M |
| 3 |
Amazon
AMZN
|
$423M |
| 4 |
Apple
AAPL
|
$190M |
| 5 |
Prologis
PLD
|
$168M |
Top Sells
| 1 |
Amgen
AMGN
|
$759M |
| 2 |
Accenture
ACN
|
$510M |
| 3 |
ConocoPhillips
COP
|
$381M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
$310M |
Sector Composition
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.72% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Transcat
TRNS
$729M
| $298K | ﹤0.01% |
+4,200
| New | +$298K |
|
2277
UWM Holdings
UWMC
$1.38B
| $297K | ﹤0.01% |
89,830
-7,112
| -7% | -$23.5K |
|
2278
Old Second Bancorp
OSBC
$970M
| $296K | ﹤0.01% |
18,482
| – | – |
|
2279
TaskUs
TASK
$1.63B
| $296K | ﹤0.01% |
17,533
+2,811
| +19% | +$47.5K |
|
2280
BioXcel Therapeutics
BTAI
$55.2M
| $294K | ﹤0.01% |
857
| – | – |
|
|
ATSG
2281
DELISTED
Air Transport Services Group, Inc.
ATSG
| $294K | ﹤0.01% |
11,319
-408
| -3% | -$10.6K |
|
|
DX
2282
Dynex Capital
DX
$1.68B
| $292K | ﹤0.01% |
22,941
+4,130
| +22% | +$52.5K |
|
2283
Inogen
INGN
$219M
| $292K | ﹤0.01% |
14,798
| – | – |
|
|
AMPS
2284
DELISTED
Altus Power, Inc.
AMPS
| $292K | ﹤0.01% |
44,718
| – | – |
|
2285
MidWestOne Financial Group
MOFG
$618M
| $291K | ﹤0.01% |
+9,164
| New | +$291K |
|
2286
Coastal Financial
CCB
$1.66B
| $290K | ﹤0.01% |
+6,100
| New | +$290K |
|
2287
Purple Innovation
PRPL
$122M
| $289K | ﹤0.01% |
60,386
| – | – |
|
2288
Frontline
FRO
$4.93B
| $289K | ﹤0.01% |
23,786
-36,261
| -60% | -$440K |
|
2289
Peapack-Gladstone Financial
PGC
$510M
| $285K | ﹤0.01% |
7,664
| – | – |
|
2290
Tejon Ranch
TRC
$446M
| $284K | ﹤0.01% |
15,069
| – | – |
|
2291
Accel Entertainment
ACEL
$967M
| $284K | ﹤0.01% |
36,827
-15,994
| -30% | -$123K |
|
2292
BrightView Holdings
BV
$1.36B
| $283K | ﹤0.01% |
41,129
-4,500
| -10% | -$31K |
|
|
AGTI
2293
DELISTED
Agiliti, Inc.
AGTI
| $282K | ﹤0.01% |
17,313
+2,711
| +19% | +$44.2K |
|
2294
Karyopharm Therapeutics
KPTI
$57.2M
| $282K | ﹤0.01% |
5,525
+724
| +15% | +$36.9K |
|
2295
Nuvation Bio
NUVB
$1.33B
| $281K | ﹤0.01% |
146,590
+4,216
| +3% | +$8.1K |
|
2296
Cardlytics
CDLX
$49.6M
| $280K | ﹤0.01% |
48,376
-310
| -0.6% | -$1.79K |
|
2297
iShares Russell 1000 Growth ETF
IWF
$117B
| $279K | ﹤0.01% |
+1,300
| New | +$279K |
|
|
BFS
2298
Saul Centers
BFS
$812M
| $278K | ﹤0.01% |
6,844
| – | – |
|
2299
REX American Resources
REX
$1.02B
| $278K | ﹤0.01% |
8,727
| – | – |
|
2300
Heron Therapeutics
HRTX
$201M
| $277K | ﹤0.01% |
110,752
| – | – |
|